OLYMPUS CORP/S (OTCMKTS:OCPNY) Downgraded by Zacks Investment Research

Zacks Investment Research cut shares of OLYMPUS CORP/S (OTCMKTS:OCPNY) from a hold rating to a sell rating in a research note released on Wednesday, Zacks.com reports.

According to Zacks, “OLYMPUS CORPORATION is a Japan-based company. The Company is engaged in the manufacturing and selling of precision machineries and instruments. The businesses of the Company include Imaging System Business, Medical Systems Business, Life Science Business, Information and Communication Business, and Others Business. Olympus has always been a company that makes people’s dreams come true through innovative products. Olympus cameras have always been at the leading edge of innovation. “

Separately, ValuEngine cut shares of Woodward, Inc.Common Stock from a buy rating to a hold rating in a research report on Tuesday, April 9th.

Shares of OCPNY opened at $11.03 on Wednesday. The stock has a fifty day simple moving average of $11.31. OLYMPUS CORP/S has a fifty-two week low of $6.26 and a fifty-two week high of $12.30. The company has a market capitalization of $14.82 billion, a PE ratio of 220.60, a PEG ratio of 2.46 and a beta of 0.60. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.59 and a quick ratio of 1.05.


Olympus Corporation manufactures and sells precision machineries and instruments worldwide. The company operates through four segments: Medical Business, Scientific Solutions Business, Imaging Business, and Others. It offers endoscopic video endoscopy systems, endoscopic ultrasound systems, ultrasound endoscopes and probes, endoscopic ultrasound observation devices, capsule endoscopy systems, integrated documentation systems, therapeutic equipment, and ancillary products; cleaning, disinfecting, and sterilization systems; gastrointestinal, colono, duodeno, and broncho endoscopes; endoscopy products for gastroenterological surgery, bronchial surgery, urology, gynecology, orthopedic surgery, neurosurgery, and anesthesiology, as well as ear, nose, and throat; and therapeutic and surgical equipment, endoscope ancillary equipment, and endotherapy devices.

Recommended Story: Index Funds

Get a free copy of the Zacks research report on OLYMPUS CORP/S (OCPNY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for OLYMPUS CORP/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OLYMPUS CORP/S and related companies with MarketBeat.com's FREE daily email newsletter.